By THE ASSOCIATED PRESSJAN. 30, 2015
Federal health regulators have approved an attention-deficit disorder drug for a new use as a first-of-its kind treatment for binge-eating disorder. The Food and Drug Administration approved the drug, Vyvanse, as a once-a-day pill for attention deficit in 2007. On Friday, the agency cleared it for adults who compulsively overeat, based on two studies in which adults binge-eaters had fewer instances per week while taking Vyvanse, compared with those getting a placebo. Side effects of the drug, made by Shire, can include psychiatric problems.A version of this brief appears in print on January 31, 2015, on Page B2 of the New York edition with the headline: F.D.A. Approves a Drug for Binge-Eating Disorder.  Order Reprints| Today's Paper|Subscribe

Weâ€™re interested in your feedback on this page. Tell us what you think.